A systematic review and meta-analysis of familial prostate cancer risk

BJU International

Volumn 91, Issue 9, 2003, Pages 789-794

  Johns, L E ^a   Houlston, R S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Familial risk; Meta analysis; Prostate cancer

Indexed keywords

CANCER RISK; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; FAMILIAL DISEASE; FAMILY HISTORY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RELATIVE; REVIEW; STATISTICAL ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FAMILY; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 0037635390     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04232.x     Document Type: Review

References (51)

1. Majeed A, Babb P, Jones J, Quinn M. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971-98. BJU Int 2000; 85: 1058-62
2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985-1993. Int J Cancer 2002; 54: 594-606
3. Nair B, Wilt T, MacDonald R, Rutks I. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer. Cochrane Database Syst Rev, CD 003506
4. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Int Med 1993; 118: 793-803
5. Goldgar DE, Easton DF, Cannon-Albright LA et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 1600-8
6. Ghadirian P, Cadotte M, Lacroix A, Perret C. Family aggregation of cancer of the prostate in Quebec: the tip of the iceberg. Prostate 1991; 19: 43-52
7. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. 1 and 2. Lyon: IARC 1987
8. Pharoah DP, Day NE, Duffy S, Easton DF, Ponder BAJ. Family history and risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997; 71: 800-9
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177-88
10. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997 1998; 315: 629-34
11. Morgani G, Gianferrari L, Cresseri A, Arrigoni G, Lovati G. Rechrches clincostatistiques et genetiques sur les neoplasmies de la prostate. Acta Genet 1956; 6: 304-5
12. Steele R, Lees REM, Kraus AS, Rao C. Sexual factors in the epidemiology of cancer of the prostate. J Chron Dis 1971; 24: 29-37
13. Schuman LM, Mandel J, Blackard C, Bauer H, Scarlett J, Mchugh R. Epidemiologic study of prostatic cancer: Preliminary report. Cancer Treat Rep 1977; 61: 181-6
14. Cannon L, Bishop DT, Skolnick M et al. Genetic epidemiology of prostate cancer in the Utah Mormon Genealogy. Cancer Surveys 1982; 1: 47-69
15. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990; 17: 337-47
16. Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991; 146: 1305-7
17. Whittemore AS, Wu AH, Kolonel LN et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Can Am J Epidemiol 1995; 141: 732-40
18. Keetch DW, Rice JP, Suarez BK, Catalona WJ. Familial aspects of prostate cancer: a case control study. J Urol 1995; 154: 2100-2
19. Hayes RB, Liff JM, Pottern LM et al. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 1995; 60: 361-4
20. Isaacs SD, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 1995; 87: 991-6
21. Lesko SM, Rosenberg L, Shapiro S. Family history and prostate cancer risk. Am J Epidemiol 1996; 144: 1041-7
22. Ghadirian P, Howe GR, Hislop TG, Maisonneuve P. Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer 1997; 70: 679-81
23. Glover FE Jr, Coffey DS, Douglas LL et al. Familial study of prostate cancer in Jamaica. Urology 1998; 52: 441-3
24. Bratt O, Kristoffersson U, Lundgren R, Olsson H. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer 1999; 35: 272-7
25. Hemminki K, Czene K. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database. Cancer 2002; 95: 1346-53
26. Hemminki K, Dong C. Familial prostate cancer from the family-cancer database. Eur J Cancer 2000; 36: 229-34
27. Krain LS. Some epidemiologic variables in prostatic carcinoma in California. Prev Med 1974; 3: 154-9
28. Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960; 13: 739-44
29. Meikle AW, Smith JA, West DW. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. The Prostate 1985; 6: 121-8
30. Gronberg H, Damber L, Damber JE. Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer 1996; 77: 138-43
31. Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85
32. Smith JR, Freije D, Carpten JD et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genomewide search. Science 1996; 274: 1371-4
33. Valeri E, Drelon T, Paiss W et al. Genetic analysis of familial prostatic cancer: localisation of a gene predisposing to prostate cancer (PCaP) on chromosome 1q42.2-43. Prog Urol 1999; 9: 680-8
34. Xu J, Meyers D, Freije D et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998; 20: 175-9
35. Gibbs M, Stanford JL, McIndoe RA et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999; 64: 776-87
36. Bock CH, Cunningham JM, McDonnell SK et al. Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. Am J Hum Genet 2001; 68: 795-801
37. Tavtigian SV, Simard J, Teng DHF, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nature Genet 2001; 27: 172-80
38. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV. Mutation of the MXI1 gene in prostate cancer. Nature Genet 1995; 9: 249-55
39. Cancel-Tassin G, Latil A, Valeri A et al. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe. Eur J Hum Genet 2001; 9: 135-42
40. McIndoe RA, Stanford JL, Gibbs M et al. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet 1997; 61: 347-53
41. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A 1992; 89: 3367-71
42. Gronberg H, Damber L, Damber JE, Iselius L. Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am J Epidemiol 1997; 146: 552-7
43. Cui J, Staples MP, Hopper JL, English DR, McCredie MR, Giles GG. Segregation analyses of 1476 population-based Australian families affected by prostate cancer. Am J Hum Genet 2001; 68: 1207-18
44. Rokman A, Ikonen T, Seppala EH et al. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 2002; 70: 1299-304
45. Gong G, Oakley-Girvan I, Wu AH et al. Segregation analysis of prostate cancer in 1,719 white African-American and Asian-American families in the United States and Canada. Cancer Causes Control 2002; 13: 471-82
46. Ellison L, Cheli C, Bright S, Veltri R, Partin A. Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screening. Urology 2002; 60: 42
47. Hall RR. Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against. Eur Urol 1996; 29 (Suppl. 2): 24-6
48. Hanus MC, Zagars GK, Pollack A. Familial prostate cancer: outcome following radiation therapy with or without adjuvant androgen ablation. Int J Radiat Oncol Biol Phys 1999; 43: 379-83
49. Gronberg H, Damber L, Tavelin B, Damber JE. No difference in survival between sporadic, familial and hereditary prostate cancer. Br J Urol 1998; 82: 564-7
50. Bauer JJ, Srivastava S, Connelly RR et al. Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy. Urology 1998; 51: 970-6
51. Valeri A, Azzouzi R, Drelon E et al. Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate 2000; 45: 66-71